Showing results (61-70 of 281) with videos related to
Sort By:
Pageof 29
La Ricerca in Clinica E in Laboratorio|April 1, 1985
Prevalence of antithrombin III deficiency in blood donors selected for personal or familial history of venous thrombosisG Finazzi, E Radice, A Armato, et al.Acta Haematologica|January 1, 1983
Fatal pulmonary embolism and antithrombin III deficiency in adult lymphoblastic leukaemia during L-asparaginase therapyT Barbui, F Rodeghiero, S Meli, et al.European Journal of Cancer & Clinical Oncology|July 1, 1986
Generation of procoagulant activity by hairy cells in response to endotoxin and phorbol estersP Viero, S Cortelazzo, T Barbui, et al.La Ricerca in Clinica E in Laboratorio|October 1, 1982
Diagnostic and prognostic significance of platelet-bound IgG measurement in immune thrombocytopenic purpuraT Barbui, S Cortelazzo, C Casarotto, et al.Acta Orthopaedica Scandinavica|April 3, 1998
Postoperative blood salvage in hip and knee arthroplasty. A prospective study on cost effectiveness in 161 patientsL Rizzi, P Bertacchi, L M Ghezzi, et al.Blood Cancer Journal|February 3, 2016
Rationale for revision and proposed changes of the WHO diagnostic criteria for polycythemia vera, essential thrombocythemia and primary myelofibrosisT Barbui, J Thiele, A M Vannucchi, et al.Blood|July 15, 1995
Kaolin clotting time and dilute Russell's viper venom time distinguish between prothrombin-dependent and beta 2-glycoprotein I-dependent antiphospholipid antibodiesM Galli, G Finazzi, E M Bevers, et al.Leukemia|January 21, 2014
An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasmsA Tefferi, J Thiele, A M Vannucchi, et al.Leukemia|March 8, 2013
Problems and pitfalls regarding WHO-defined diagnosis of early/prefibrotic primary myelofibrosis versus essential thrombocythemiaT Barbui, J Thiele, A M Vannucchi, et al.Leukemia|December 20, 2013
Rethinking the diagnostic criteria of polycythemia veraT Barbui, J Thiele, A M Vannucchi, et al.Pageof 29